Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Care Career has acquired MAS Medical Staffing, its seventh acquisition in 24 months. The deal adds MAS Medical Staffing's clinician network, client relationships, and MAESTRA engagement technology to Care Career's AI powered workforce platform.
MindWalk Holdings gave the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, at AMD's Advancing AI 2026 event in San Francisco.
Orbiva, a Home Control International subsidiary, signed an MOU with Indonesia's Articura to explore healthcare AI infrastructure and digital health tools for local hospitals and clinics.
VELMENI has received FDA 510(k) clearance for VELMENI for DENTISTS 3D, software that uses AI to assist dental professionals with CBCT scan review and analysis.
Cognizant and Gulf Edge Company Limited have formed a strategic partnership to deliver AI services across Thailand, with an initial focus on banking, energy, healthcare, telecom, manufacturing, and the public sector.
DarioHealth Corp. announced the pricing of a $23.5 million registered direct offering of common stock, with shares priced at $6.80 each. The offering is expected to close on or about July 23, 2026, subject to customary conditions.
Health Endeavors has introduced an AI-based care management suite called Alex and secured funding from Decathlon Capital Partners to support expansion and technology advancement.
Nordic Capital has agreed to sell life sciences software provider ArisGlobal to Dassault Systèmes. The deal marks a full exit for Nordic Capital following its investment in 2019 and is expected to close in the second half of 2026, pending regulatory approval.
Agilisium has been named a Select Services Partner in Anthropic’s Claude Partner Network, expanding its work with Claude-powered AI solutions for Life Sciences clients.
Tally has announced a collaboration with Liminal to automate complex billing operations for specialty healthcare providers using its agentic AI platform. The partnership targets inefficiencies in the U.S. revenue cycle management market, valued at over $125 billion.
Moon Surgical has entered a strategic commercial collaboration with KARL STORZ to integrate the Maestro platform with KARL STORZ 3D visualization and instrumentation, aiming to expand access to advanced laparoscopic surgery.
Sentante has received CE marking for its haptic endovascular robotic platform designed for remote vascular procedures. The system captures force, torque, and motion data from each procedure, laying the groundwork for future AI-supported endovascular interventions.
Cigna Healthcare announced an AI expansion to its personalized care management programs, aiming to identify health needs sooner and connect more customers with clinical support.
SimBioSys has partnered with Ferrum Health to make its FDA-cleared TumorSight Viz platform available through Ferrum's Model Hub, improving deployment and management of AI surgical planning capabilities across U.S. health systems.
Genesis Automation Healthcare will debut its unified platform and introduce the Agentic AI Design Partner Program at AHRMM26 in San Antonio, marking its first public appearance as a combined company.
An independent American Heart Association AI Impact Report found that Ultromics' EchoGo Heart Failure system could identify heart failure with preserved ejection fraction up to nine months earlier than standard care.
EBSCO Clinical Decisions has partnered exclusively with the International Home Care Nurses Organization to integrate validated clinical competencies into its Dynamic Health platform, providing home care professionals with evidence-based guidance for safer patient care.
The Digital Medicine Society (DiMe) has introduced a new initiative, 'Operationalizing AI Governance in Healthcare', to provide practical tools and templates for responsible AI deployment in healthcare systems, developed with Qualified Health as the title sponsor.
Karoo Health has secured $16.2 million in Series A funding, co-led by 7wire Ventures and Allumia Ventures, to expand its AI cardiovascular care platform and partnerships with health plans and cardiology providers.
Bristol Myers Squibb will deploy NVIDIA's DGX Vera Rubin NVL72 systems to enhance its AI capabilities across drug discovery and development, expanding its existing collaboration with the chipmaker to create the most powerful AI infrastructure in life sciences.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
